| Tocilizumab in patients with systemic sclerosis-associated interstitial lung disease: a systematic review and meta-analysis. | 2024 | Annals of the American Thoracic Society |
| Oral glucocorticoid use in patients with rheumatoid arthritis initiating TNF-inhibitors, tocilizumab or abatacept: results from the international TOCERRA and PANABA observational collaborative studies. | 2024 | Joint Bone Spine |
| Assessment of the available therapeutic approaches for severe COVID-19: a meta-analysis of randomized controlled trials. | 2023 | Scientific Reports |
| Efficacy and safety of tocilizumab and baricitinib among patients hospitalized for COVID-19: a systematic review and meta-analysis. | 2023 | Frontiers in Pharmacology |
| Effectiveness of tocilizumab in non-intubated cases with COVID-19: a systematic review and meta-analysis. | 2023 | Infection |
| Efficacy and safety of interleukin-6 receptor antagonists in adult patients admitted to intensive care unit with COVID-19: a systematic review and meta-analysis of randomized controlled trials. | 2023 | Preventive Medicine Reports |
| Interleukin-6 blocking agents for treating COVID-19: a living systematic review. | 2023 | Cochrane Database of Systematic Reviews |
| Effect of tocilizumab, sarilumab, and baricitinib on mortality among patients hospitalized for COVID-19 treated with corticosteroids: a systematic review and meta-analysis. | 2023 | Clinical Microbiology and Infection |
| Randomized clinical trials on the efficacy and safety of tocilizumab in subjects with rheumatoid arthritis: a systematic review. | 2023 | Current Reviews in Clinical and Experimental Pharmacology |
| Genetic biomarkers as predictors of response to tocilizumab in rheumatoid arthritis: a systematic review and meta-analysis. | 2022 | Genes |
| Effectiveness of tocilizumab in the treatment of hospitalized adults COVID-19: a systematic review and meta-analysis. | 2022 | Medicine Open |
| Efficacy and harms of tocilizumab for the treatment of COVID-19 patients: a systematic review and meta-analysis. | 2022 | PLoS One |
| Australian public assessment report for tocilizumab (RCH). | 2022 | Australian Government Department of Health |
| Clinical efficacy and safety of interleukin-6 receptor antagonists (tocilizumab and sarilumab) in patients with COVID-19: a systematic review and meta-analysis. | 2022 | Emerging Microbs and Infections |
| Associations between the interleukin-6 rs1800795 G/C and interleukin-6 receptor rs12083537 A/G polymorphisms and response to disease-modifying antirheumatic drugs in rheumatoid arthritis: a meta-analysis. | 2022 | International Immunopharmacology |
| Indirect comparison of glucocorticoid-sparing agents for remission maintenance in giant cell arteritis: a network meta-analysis. | 2022 | Mayo Clinic Proceedings |
| A systematic literature review informing the consensus statement on efficacy and safety of pharmacological treatment with interleukin-6 pathway inhibition with biological DMARDs in immune-mediated inflammatory diseases. | 2022 | RMD Open |
| Efficacy of pharmacological interventions in COVID-19: a network meta-analysis. | 2022 | British Journal of Clinical Pharmacology |
| Efficacy and safety of baricitinib and tocilizumab in hospitalized patients with COVID-19: a comparison using systematic review and meta-analysis. | 2022 | Frontiers in Pharmacology |
| Association between tocilizumab, sarilumab and all-cause mortality at 28 days in hospitalised patients with COVID-19: a network meta-analysis. | 2022 | PLoS One |
| Efficacy of COVID-19 treatments among geriatric patients: a systematic review. | 2022 | Therapeutic Advances in Infectious Disease |
| Tocilizumab for giant cell arteritis. | 2022 | Cochrane Database of Systematic Reviews |
| Tocilizumab in addition to standard of care in the management of COVID-19: a meta-analysis of RCTs. | 2022 | Acta Biomedica |
| Efficacy and secondary infection risk of tocilizumab, sarilumab and anakinra in COVID-19 patients: a systematic review and meta-analysis. | 2022 | Reviews in Medical Virology |
| Efficacy and safety of tocilizumab versus standard care/placebo in patients with COVID-19; a systematic review and meta-analysis of randomized clinical trials. | 2022 | British Journal of Clinical Pharmacology |
| Mortality rates among hospitalized patients with COVID-19 infection treated with tocilizumab and corticosteroids: a Bayesian reanalysis of a previous meta-analysis. | 2022 | JAMA Network Open |
| Use of tocilizumab and sarilumab alone or in combination with corticosteroids for covid-19: systematic review and network meta-analysis. | 2022 | BMJ Medicine |
| Efficacy and safety of tocilizumab in the management of COVID-19: a systematic review and meta-analysis of observational studies. | 2022 | Clinical and Experimental Rheumatology |
| Efficacy and safety of immunomodulators in patients with COVID-19: a systematic review and network meta-analysis of randomized controlled trials. | 2022 | Infectious Diseases and Therapy |
| Specific interleukin-1 inhibitors, specific interleukin-6 inhibitors, and GM-CSF blockades for COVID-19 (at the edge of sepsis): a systematic review. | 2022 | Frontiers in Pharmacology |
| Association between tocilizumab treatment and clinical outcomes of COVID-19 patients: a systematic review and meta-analysis. | 2022 | Aging |
| Comparative efficacy and safety of biologic agents in patients with active rheumatoid arthritis and inadequate response to tumor necrosis factor inhibitors: a Bayesian network meta-analysis of randomized controlled trials. | 2022 | International Journal of Clinical Pharmacology and Therapeutics |
| Tocilizumab in patients hospitalized with COVID-19 pneumonia: systematic review and meta-analysis of randomized controlled trials. | 2022 | Journal of Investigative Medicine |
| The use of tocilizumab in patients with COVID-19: a systematic review, meta-analysis and trial sequential analysis of randomized controlled studies. | 2021 | Journal of Clinical Medicine |
| Tocilizumab and systemic corticosteroids in the management of patients with COVID-19: a systematic review and meta-analysis. | 2021 | International Journal of Infectious Diseases |
| Efficacy and secondary infection risk of tocilizumab, sarilumab and anakinra in COVID-19 patients: a systematic review and meta-analysis. | 2021 | Reviews in Medical Virology |
| Tocilizumab administration for the treatment of hospitalized patients with COVID-19: a systematic review and meta-analysis. | 2021 | Respirology |
| Safety and efficacy of tocilizumab for rheumatoid arthritis: a systematic review and meta-analysis of clinical trial studies. | 2021 | Reumatologia |
| Tocilizumab in the treatment of COVID-19-A meta-analysis. | 2021 | International Journal of Medicine |
| Rationale and evidence on the use of tocilizumab in COVID-19: a systematic review. | 2021 | Pulmonology |
| Assessment report: RoActemra. | 2021 | European Medicines Agency |
| Systematic review on treatment trials of tocilizumab: a repurposing drug against COVID-19. | 2021 | Reviews on Recent Clinical Trials |
| A systematic review on treatment-related mucocutaneous reactions in COVID-19 patients. | 2021 | Dermatologic Therapy |
| Comparative efficacy and safety of pharmacological interventions for the treatment of COVID-19: a systematic review and network meta-analysis. | 2021 | PLoS Medicine |
| Tocilizumab for treating COVID-19: a systemic review and meta-analysis of retrospective studies. | 2021 | European Journal of Clinical Pharmacology |
| Efficacy of tocilizumab in COVID-19: a systematic review and meta-analysis. | 2021 | Journal of Medical Virology |
| Efficacy and safety of tocilizumab in COVID-19 patients: a living systematic review and meta-analysis. | 2021 | Clinical Microbiology and Infection |
| Efficacy and safety of tocilizumab for coronavirus disease 2019 (COVID-19) patients: a systematic review and meta-analysis. | 2021 | Drug Research |
| Interleukin-6 blocking agents for treating COVID-19: a living systematic review. | 2021 | Cochrane Database of Systematic Reviews |
| Comparison of the efficacy and safety of biological agents in patients with systemic juvenile idiopathic arthritis: a Bayesian network meta-analysis of randomized controlled trials. | 2021 | International Journal of Clinical Pharmacology and Therapeutics |
| Interventions for treatment of COVID-19: second edition of a living systematic review with meta-analyses and trial sequential analyses (The LIVING Project). | 2021 | PLoS One |
| Decreased mortality in coronavirus disease 2019 patients treated with tocilizumab: a rapid systematic review and meta-analysis of observational studies. | 2021 | Clinical Infectious Diseases |
| Tocilizumab as treatment for COVID-19: a systematic review and meta-analysis. | 2021 | World Journal of Methodology |
| Efficacy and safety of tocilizumab in severe and critical COVID-19: a systematic review and meta-analysis. | 2021 | Expert Review of Clinical Immunology |
| IL-6 inhibition in the treatment of COVID-19: a meta-analysis and meta-regression. | 2021 | Journal of Infection |
| A complementary critical appraisal on systematic reviews regarding the most efficient therapeutic strategies for the current COVID-19 (SARS-CoV-2) pandemic. | 2021 | Journal of Medical Virology |
| Tocilizumab in hospitalized patients with COVID-19: a meta analysis of randomized controlled trials. | 2021 | Lung |
| Tocilizumab in COVID-19: a meta-analysis, trial sequential analysis, and meta-regression of randomized-controlled trials. | 2021 | Intensive Care Medicine |
| Systematic review and meta-analysis of tocilizumab in persons with coronavirus disease-2019 (COVID-19). | 2021 | Leukemia |
| Immunomodulatory therapies for SARS-CoV-2 infection: a systematic literature review to inform EULAR points to consider. | 2021 | Annals of Rheumatic Diseases |
| Efficacy and safety of steroid-sparing treatments in giant cell arteritis according to the glucocorticoids tapering regimen: a systematic review and meta-analysis. | 2021 | European Journal of Internal Medicine |
| Giant cell arteritis: a systematic review and meta-analysis of test accuracy and benefits and harms of common treatments. | 2021 | ACR Open Rheumatology |
| The effect of tocilizumab on COVID-19 patient mortality: a systematic review and meta-analysis of randomized controlled trials. | 2021 | International Immunopharmacology |
| Effect of tocilizumab in reducing the mortality rate in COVID-19 patients: a systematic review with meta-analysis. | 2021 | Journal of Personalized Medicine |
| Comparison of the efficacy and safety indicators of DMARDs for rheumatoid arthritis: a network meta-analysis. | 2021 | Medicine |
| The effect of tocilizumab on mortality in hospitalized patients with COVID-19: a meta-analysis of randomized controlled trials. | 2021 | European Journal of Clinical Pharmacology |
| Efficacy and safety of tocilizumab in COVID-19 patients: a living systematic review and meta-analysis, first update. | 2021 | Clinical Microbiology and Infection |
| Tocilizumab treatment for COVID-19 patients: a systematic review and meta-analysis. | 2021 | Infectious Diseases of Poverty |
| Comparison of the efficacy and safety of tocilizumab, sarilumab, and sirukumab in comparison with adalimumab as monotherapy in patients with active rheumatoid arthritis: a Bayesian network meta-analysis of randomized controlled trials. | 2021 | International Journal of Clinical Pharmacology and Therapeutics |
| Tocilizumab and systemic corticosteroids in the management of patients with COVID-19: a systematic review and meta-analysis. | 2021 | International Journal of Infectious Diseases |
| Systematic review and subgroup meta-analysis of randomized trials to determine tocilizumab's place in COVID-19 pneumonia. | 2021 | Infectious Diseases and Therapy |
| Systematic review and meta-analysis of anakinra, sarilumab, siltuximab and tocilizumab for COVID-19. | 2021 | Thorax |
| Systematic review and meta-analysis of tocilizumab therapy versus standard of care in over 15,000 COVID-19 pneumonia patients during the first eight months of the pandemic. | 2021 | International Journal of Environmental Research and Public Health |
| Tocilizumab for giant cell arteritis. | 2021 | Cochrane Database of Systematic Reviews |
| Association between administration of IL-6 antagonists and mortality among patients hospitalized for COVID-19: a meta-analysis. | 2021 | Journal of the American Medical Association |
| Tocilizumab for the treatment of immune-related adverse events: a systematic literature review and a multicentre case series. | 2021 | European Journal of Internal Medicine |
| The use of tocilizumab in patients with COVID-19: a systematic review, meta-analysis and trial sequential analysis of randomized controlled studies. | 2021 | Journal of Clinical Medicine |
| Immunomodulatory therapies for the treatment of SARS-CoV-2 infection: an update of the systematic literature review to inform EULAR points to consider. | 2021 | RMD Open |
| Efficacy of COVID-19 treatments: a Bayesian network meta-analysis of randomized controlled trials. | 2021 | Frontiers in Public Health |
| Beneficial and harmful outcomes of tocilizumab in severe COVID-19: a systematic review and meta-analysis. | 2021 | Pharmacotherapy |
| Tocilizumab administration for the treatment of hospitalized patients with COVID-19: a systematic review and meta-analysis. | 2021 | Respirology |
| Effectiveness of tocilizumab in Behcet's disease: a systematic literature review. | 2020 | Seminars in Arthritis and Rheumatism |
| Tocilizumab for the treatment of TAFRO syndrome: a systematic literature review. | 2020 | Annals of Hematology |
| Tocilizumab for severe COVID-19: a systematic review and meta-analysis. | 2020 | International Journal of Antimicrobial Agents |
| Efficacy and safety of tocilizumab in COVID-19 patients: a living systematic review and meta-analysis. | 2020 | Clinical Microbiology and Infection |
| Efficacy of tocilizumab in COVID-19: a systematic review and meta-analysis. | 2020 | Journal of Medical Virology |
| Comparative efficacy and safety of pharmacological interventions for the treatment of COVID-19: a systematic review and network meta-analysis. | 2020 | PLoS Medicine |
| Addition of tocilizumab to the standard of care reduces mortality in severe COVID-19: a systematic review and meta-analysis. | 2020 | Frontiers in Medicine |
| Clinical outcomes in COVID-19 patients treated with tocilizumab: an individual patient data systematic review. | 2020 | Journal of Medical Virology |
| Efficacy of various treatment modalities for nCOV-2019: a systematic review and meta-analysis. | 2020 | European Journal of Investigation |
| Mortality in tocilizumab-treated patients with COVID-19: a systematic review and meta-analysis. | 2020 | Clinical and Experimental Rheumatology |
| Efficacy and safety of biological agents in patients with giant cell arteritis: a meta-analysis of randomized trials. | 2020 | International Journal of Clinical Pharmacology and Pharmaceutics |
| The benefit-risk balance for biological agents in juvenile idiopathic arthritis: a meta-analysis of randomized clinical trials. | 2020 | Rheumatology |
| A systematic review of trial registry entries for randomized clinical trials investigating COVID-19 medical prevention and treatment. | 2020 | PLoS One |
| Comparison of adverse events of biologicals for treatment of juvenile idiopathic arthritis: a systematic review. | 2019 | Expert Opinion on Drug Safety |
